FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Mandeli

Research Profile

Procedures

Living Beings

Concepts & Ideas

Chemicals & Drugs

Disorders

Anatomy

Physiology

Gene Expression Regulation, Neoplastic

Co-author Network

Publications

TOP 3
Keith Sigel; Gary Strauss; Jessica Cohen; Ethan A Halm; John Mandeli; Grace Mhango; Juan Wisnivesky
Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
XiaoMei Liu; Charisse Loder; John Mandeli; Jonathan Melamed; Carole Oddoux; Ruifang Qiao; Pamela D Unger; Enrique Carrillo-de Santa Pau; Robert E Gallagher; Alejandro Gomez-Pinillos; Ralf Kurek; Anna C Ferrari
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
Beatriz Mínguez; Sasan Roayaie; Radoslav Savic; Myron Schwartz; Daniela Sia; Swan Thung; Sara Toffanin; Augusto Villanueva; Craig April; Jordi Bruix; Laia Cabellos; Jian-Bing Fan; Scott L Friedman; Yujin Hoshida; Anja Lachenmayer; John Mandeli; Vincenzo Mazzaferro; Josep M Llovet
Gene-expression signature of vascular invasion in hepatocellular carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Mandeli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Keith Sigel; Gary Strauss; Jessica Cohen; Ethan A Halm; John Mandeli; Grace Mhango; Juan Wisnivesky
Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
Annals of surgical oncology 2013;20(3):1013-9.
2012: XiaoMei Liu; Charisse Loder; John Mandeli; Jonathan Melamed; Carole Oddoux; Ruifang Qiao; Pamela D Unger; Enrique Carrillo-de Santa Pau; Robert E Gallagher; Alejandro Gomez-Pinillos; Ralf Kurek; Anna C Ferrari
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
The American journal of pathology 2012;181(3):1007-16.
2011: Beatriz Mínguez; Sasan Roayaie; Radoslav Savic; Myron Schwartz; Daniela Sia; Swan Thung; Sara Toffanin; Augusto Villanueva; Craig April; Jordi Bruix; Laia Cabellos; Jian-Bing Fan; Scott L Friedman; Yujin Hoshida; Anja Lachenmayer; John Mandeli; Vincenzo Mazzaferro; Josep M Llovet
Gene-expression signature of vascular invasion in hepatocellular carcinoma.
Journal of hepatology 2011;55(6):1325-31.
2011: Min Lu; John Mandeli; Salim Merali; Jiandong Jiang; Yan Li; Xunbao Duan; John Fallon; Ronald Gordon; James F Holland
Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice.
Genes & cancer 2011;2(10):985-92.
2011: Juan P Wisnivesky; Jacqueline Arciniega; Grace Mhango; John Mandeli; Ethan A Halm
Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer.
Thorax 2011;66(4):287-93.
2011: Micsunica Platica; Alin Ionescu; Elena Ivan; James F Holland; John Mandeli; Ovidiu Platica
PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins.
International journal of oncology 2011;38(3):777-85.
2010: Keren Osman; Brian Elliott; John Mandeli; Eileen Scigliano; Adriana Malone; Luis Isola; Celia Grosskreutz
Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma.
American journal of hematology 2010;85(4):249-54.
2010: Zhiyu Li; John Fallon; John Mandeli; James G Wetmur; Savio L C Woo
Retraction: A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.
Journal of the National Cancer Institute 2010;102(4):283.
2009: Zhiyu Li; John Fallon; John Mandeli; James G Wetmur; Savio L C Woo
The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene.
Human gene therapy 2009;20(7):751-8.
2009: Jennifer Altomonte; L Wu; Marcia Meseck; Li Chen; Oliver Ebert; Adolfo Garcia-Sastre; John Fallon; John Mandeli; S L C Woo
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells.
Cancer gene therapy 2009;16(3):266-78.
2009: Yelena Sinitsyn; Adriana Malone; John Mandeli; Celia Grosskreutz; Keren Osman; Eileen Scigliano; Patricia Shi; Luis Isola
Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Cytotherapy 2009;11(4):457-63.
2008: Zhiyu Li; John Fallon; John Mandeli; James G Wetmur; Savio L C Woo
A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.
Journal of the National Cancer Institute 2008;100(19):1389-400.
2008: Abby B Siegel; Emil I Cohen; Allyson Ocean; Deborah Lehrer; Alec Goldenberg; Jennifer J Knox; Helen Chen; Sean Clark-Garvey; Alan Weinberg; John Mandeli; Paul Christos; Madhu Mazumdar; Elizabeta Popa; Robert S Brown; Shahin Rafii; Jonathan D Schwartz
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2992-8.
2008: Lan Wu; Tian-Gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.
Human gene therapy 2008;19(6):635-47.
2007: Li Chen; Tian-Gui Huang; Marcia Meseck; John Mandeli; John Fallon; Savio Lc Woo
Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(12):2194-202.
2007: Mariana Fernandez-Cobo; Francesca Zammarchi; John Mandeli; James F Holland; Beatriz G T Pogo
Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells.
Oncology reports 2007;17(4):903-7.
2006: Yuki Ishii; Andreja Pirkmaier; James V Alvarez; David A Frank; Inna Keselman; Diomedes E Logothetis; John Mandeli; Matthew O'Connell; Samuel Waxman; Doris Germain
Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Journal of the National Cancer Institute 2006;98(17):1238-47.
2006: Anna C Ferrari; Nelson N Stone; Ralf Kurek; Elizabeth Mulligan; Roy McGregor; Richard Stock; Pamela Unger; Ulf Tunn; Amir Kaisary; Michael Droller; Simon Hall; Heiner Renneberg; Kenneth J Livak; Robert E Gallagher; John Mandeli
Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3081-8.
2006: Howard Hochster; Elizabeth R Plimack; John Mandeli; Scott Wadler; Carolyn D Runowicz; Gary L Goldberg; James Speyer; Robert C Wallach; Franco Muggia
Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study.
Gynecologic oncology 2006;100(2):324-9.
2005: Jonathan D Schwartz; Max Sung; Myron Schwartz; Deborah Lehrer; John Mandeli; Leonard Liebes; Alec Goldenberg; Matthew Volm
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.
The oncologist 2005;10(9):718-27.
2004: Farr Nezhat; Scott Wadler; Franco Muggia; John Mandeli; Gary L Goldberg; Jamal Rahaman; Carolyn D Runowicz; Anthony J Murgo; Ginger J Gardner
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Gynecologic oncology 2004;93(1):144-8.
2004: Micsunica Platica; Elena Ivan; Alin Ionescu; James F Holland; Gloria Mora; Donald J Tindall; John Mandeli; Pamela D Unger; Ovidiu Platica
Transformation of NIH 3T3 cells by enhanced PAR expression.
Biochemical and biophysical research communications 2004;314(3):891-6.
2004: Micsunica Platica; Elena Ivan; James F Holland; Alin Ionescu; Sheryl Chen; John Mandeli; Pamela D Unger; Ovidiu Platica
A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(6):1560-5.
2004: Howard Hochster; Elizabeth R Plimack; Carolyn D Runowicz; James Speyer; Robert C Wallach; Joan Sorich; John Mandeli; Scott Wadler; John Wright; Franco M Muggia
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):120-6.
2002: Jonathan D Schwartz; Myron Schwartz; John Mandeli; Max Sung
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials.
The lancet oncology 2002;3(10):593-603.
2002: Olivier Martinet; Celia M Divino; Y Zang; Y Gan; John Mandeli; Swan N Thung; Ping-Ying Pan; Shu-Hsia Chen
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
Gene therapy 2002;9(12):786-92.
2002: Denise Serebrisky; Romulo Cordero; John Mandeli; Meyer Kattan; Carin Lamm
Assessment of inspiratory flow limitation in children with sleep-disordered breathing by a nasal cannula pressure transducer system.
Pediatric pulmonology 2002;33(5):380-7.
2002: Max W Sung; Shu-Hsia Chen; Swan N Thung; David Y Zhang; Tian-Gui Huang; John Mandeli; Savio L C Woo
Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
Human gene therapy 2002;13(6):731-43.
2002: Anna C Ferrari; Nelson Stone; Richard Stock; Myron Bednar; Isaac Esseesse; Harvinder Singh; Yvonne Baldwin; John Mandeli
13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):538-44.
2001: Micsunica Platica; Elena Ivan; S Chen; James F Holland; J Gil; John Mandeli; Ovidiu Platica
Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice.
The Prostate 2001;49(3):200-7.
2001: Max W Sung; H C Yeh; Swan N Thung; M E Schwartz; John Mandeli; Shu-Hsia Chen; Savio L C Woo
Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(3):182-91.
2001: Anna C Ferrari; Abraham Chachoua; Harvinder Singh; M Rosenthal; Samir Taneja; M Bednar; John Mandeli; Franco Muggia
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma.
Cancer 2001;91(11):2039-45.
2001: Karen Zier; J M Maddux; K Johnson; Max Sung; John Mandeli; L Eisenbach; Myron Schwartz
Surrogate markers of antitumor responses: in vitro activation of T cells by autologous tumor peptides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):818s-821s.
2000: Karen Zier; K Johnson; J M Maddux; Max Sung; John Mandeli; L Eisenbach; Myron Schwartz
IFNgamma secretion following stimulation with total tumor peptides from autologous human tumors.
Journal of immunological methods 2000;241(1-2):61-8.
2000: Menahem Ben-Haim; John Mandeli; RL Friedman; RJ Rosenthal
Mechanisms of systemic hypertension during acute elevation of intraabdominal pressure.
The Journal of surgical research 2000;91(2):101-5.
2000: Olivier Martinet; V Ermekova; J Q Qiao; Bernhard V Sauter; John Mandeli; Li Chen; Shu-Hsia Chen
Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
Journal of the National Cancer Institute 2000;92(11):931-6.
2000: Bernhard V Sauter; Olivier Martinet; Wei-Jian Zhang; John Mandeli; Savio L C Woo
Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4802-7.
2000: Yuvarani S Kuppumbatti; Ira J Bleiweiss; John Mandeli; Samuel Waxman; Rafael Mira-Y-Lopez
Cellular retinol-binding protein expression and breast cancer.
Journal of the National Cancer Institute 2000;92(6):475-80.
1999: J Qiao; Shu-Hsia Chen; KB Pham-Nguyen; John Mandeli; Savio L C Woo
Construction and characterization of a recombinant adenoviral vector expressing human interleukin-12.
Cancer gene therapy 1999;6(4):373-9.
1999: Carin Lamm; John Mandeli; Meyer Kattan
Evaluation of home audiotapes as an abbreviated test for obstructive sleep apnea syndrome (OSAS) in children.
Pediatric pulmonology 1999;27(4):267-72.
1999: Howard Hochster; James Speyer; John Mandeli; Carolyn D Runowicz; Scott Wadler; G Berk; Robert C Wallach; James F Holland
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer.
Gynecologic oncology 1999;72(3):292-7.
1998: Abbie Fields; Howard Hochster; Carolyn D Runowicz; James Speyer; Gary L Goldberg; C Cohen; PR Dottino; Scott Wadler; G Berk; H Gretz; John Mandeli; J Holland; L Letvak
PSC833: initial clinical results in refractory ovarian cancer patients.
Current opinion in oncology 1998;10 Suppl 1():S21.
1998: A P Chahinian; John Mandeli; H Gluck; H Naim; Alvin S Teirstein; James F Holland
Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
Journal of surgical oncology 1998;67(2):104-11.
1997: Anna C Ferrari; Nelson N Stone; J N Eyler; M Gao; John Mandeli; Pamela Unger; Robert E Gallagher; Richard Stock
Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
Journal of the National Cancer Institute 1997;89(20):1498-504.
1997: R C Schiavi; D White; John Mandeli; Alice C Levine
Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction.
Archives of sexual behavior 1997;26(3):231-41.
1997: Scott Wadler; Edward L Schwartz; Hilda Haynes; R Rameau; A Quish; John Mandeli; Robert E Gallagher; S Hallam; Abbie Fields; Gary L Goldberg; F McGill; S Jennings; Robert C Wallach; Carolyn D Runowicz
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.
Cancer 1997;79(8):1574-80.
1996: A M Gattani; John Mandeli; H W Bruckner
Tumor markers in patients with pancreatic carcinoma.
Cancer 1996;78(1):57-62.
1996: Carolyn D Runowicz; John Mandeli; James Speyer; Scott Wadler; Howard Hochster; L Garrison; J F Holland
Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer.
American journal of obstetrics and gynecology 1996;174(4):1151-9; discussion 1159-60.
1995: PR Dottino; R A Segna; T S Jennings; John Mandeli; K Konsker; Carmel J Cohen
Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
The Mount Sinai journal of medicine, New York 1995;62(6):431-5.
1995: James Speyer; John Mandeli; Howard Hochster; Carolyn D Runowicz; Scott Wadler; Robert C Wallach; C Cohen; D Oette; Joan Sorich; E Demakos
A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancer.
Gynecologic oncology 1995;56(3):387-94.
1994: T S Jennings; PR Dottino; John Mandeli; R A Segna; K Kelliher; Carmel J Cohen
Growth factor expression in normal peritoneum of patients with gynecologic carcinoma.
Gynecologic oncology 1994;55(2):190-7.
1994: L R Silverman; L Deligdisch; John Mandeli; E M Greenspan
Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature.
Cancer investigation 1994;12(2):145-55.
1993: Scott Wadler; Hilda Haynes; Jonathan J Beitler; Gary L Goldberg; J F Holland; Howard Hochster; H Bruckner; John Mandeli; Harriet O Smith; Carolyn D Runowicz
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1517-22.
1993: H W Bruckner; Shalom Kalnicki; J Dalton; H Snady; Gary K Schwartz; M R Chesser; D Lehrer; John Mandeli; N Harpaz; C Janus
Survival after combined modality therapy for pancreatic cancer.
Journal of clinical gastroenterology 1993;16(3):199-203.
1993: R A Segna; PR Dottino; John Mandeli; K Konsker; Carmel J Cohen
Secondary cytoreduction for ovarian cancer following cisplatin therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):434-9.
1993: H W Bruckner; Shalom Kalnicki; J Dalton; Gary K Schwartz; M R Chesser; John Mandeli; C Janus
Combined modality therapy increasing local control of pancreatic cancer.
Cancer investigation 1993;11(3):241-6.
1993: H W Bruckner; M R Chesser; John Mandeli; L A Farber; G DiGiovanni
Circulating pancreatic polypeptide in patients with adenocarcinoma of the bile duct.
Acta oncologica (Stockholm, Sweden) 1993;32(6):627-9.
1992: Gary K Schwartz; J J Collins; A Galazka; P A Nessi; D Lehrer; Y Baldwin; John Mandeli; J F Holland
Phase I study of subcutaneously-administered bacterially-synthesised recombinant human granulocyte-macrophage colony-stimulating factor.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):470-3.
1991: H W Bruckner; M R Chesser; H Wong; John Mandeli
Folate biochemical modulation regimen for the treatment of gastric cancer.
Journal of clinical gastroenterology 1991;13(4):384-9.
1991: H W Bruckner; C Cohen; John Mandeli; M R Chesser; B Kabakow; Robert C Wallach; J Holland
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experience.
Cancer treatment reviews 1991;18 Suppl A():57-65.